Breastfeeding: The Importance and Challenges in the Infant Formula Industry
Breastfeeding is widely acknowledged as the best feeding option for infants due to its numerous health benefits for both mother and child. However, despite recommendations from the World Health Organization (WHO), global breastfeeding rates remain below 50%.
Earlier this year, The Lancet published a series of papers on breastfeeding, alleging that infant formula manufacturers engage in irresponsible marketing and political lobbying for their own gain, rather than prioritizing the well-being of parents and children.
In response, trade associations representing these manufacturers, such as the International Special Dietary Foods Industries (ISDI) and Specialised Nutrition Europe (SNE), have countered these claims. They argue that the papers wrongly suggest that advertising is the primary impediment to breastfeeding and advocate for a global ban on communication related to infant formula.
ISDI and SNE believe this perspective is misleading. They assert that while commercial marketing may play a role, low breastfeeding rates are influenced by a variety of socioeconomic and cultural factors at the national level. For instance, Scandinavian countries with extensive maternity leave and a supportive breastfeeding culture demonstrate some of the highest breastfeeding rates globally.
The trade associations emphasize the need for a holistic approach to improving breastfeeding rates. This includes strengthening maternity leave policies, workplace support, and funding. Additionally, transparent and science-based interactions with healthcare professionals are vital. These interactions must adhere to professional and ethical standards.
It is essential to address the challenges surrounding breastfeeding comprehensively. By fostering an all-inclusive supportive ecosystem involving multiple stakeholders, we can encourage breastfeeding and enhance nutritional outcomes for both mothers and infants. This approach necessitates access to accurate information about industry products for healthcare professionals, while maintaining compliance with ethical and professional guidelines.
To learn more about this topic, refer to The Lancet’s ‘Breastfeeding 2023’ publication. This valuable resource provides insights into the crucial role played by breastfeeding and the challenges faced by the commercial milk formula industry.
Sources:
– The Lancet, ‘Breastfeeding 2023’, published on 7 February 2023, accessed on 5 March 2023, available at https://www.thelancet.com/series/Breastfeeding-2023
– The Lancet, ‘Breastfeeding and the role of the commercial milk formula industry’, published on 5 August 2023, DOI: https://doi.org/10.1016/S0140-6736(23)01196-0, authored by Jean-Christophe Kremer and Beat Späth.
